- Home
- IMTX vs ABL Comparison
IMTX vs ABL Comparison
Compare IMTX & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- ABL
- Stock Information
- Founded
- IMTX N/A
- ABL 2004
- Country
- IMTX Germany
- ABL United States
- Employees
- IMTX N/A
- ABL N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- ABL Investment Managers
- Sector
- IMTX Health Care
- ABL Finance
- Exchange
- IMTX Nasdaq
- ABL Nasdaq
- Market Cap
- IMTX 579.8M
- ABL 687.7M
- IPO Year
- IMTX N/A
- ABL N/A
- Fundamental
- Price
- IMTX $4.24
- ABL $8.83
- Analyst Decision
- IMTX Strong Buy
- ABL Strong Buy
- Analyst Count
- IMTX 4
- ABL 4
- Target Price
- IMTX $16.67
- ABL $13.63
- AVG Volume (30 Days)
- IMTX 426.9K
- ABL 459.0K
- Earning Date
- IMTX 05-20-2025
- ABL 05-08-2025
- Dividend Yield
- IMTX N/A
- ABL N/A
- EPS Growth
- IMTX N/A
- ABL N/A
- EPS
- IMTX 0.14
- ABL N/A
- Revenue
- IMTX $161,336,577.00
- ABL $134,575,948.00
- Revenue This Year
- IMTX N/A
- ABL $64.80
- Revenue Next Year
- IMTX $4.92
- ABL $24.39
- P/E Ratio
- IMTX $29.25
- ABL N/A
- Revenue Growth
- IMTX 188.60
- ABL 73.39
- 52 Week Low
- IMTX $3.30
- ABL $6.34
- 52 Week High
- IMTX $13.77
- ABL $12.40
- Technical
- Relative Strength Index (RSI)
- IMTX 43.11
- ABL 70.94
- Support Level
- IMTX $3.94
- ABL $8.12
- Resistance Level
- IMTX $5.41
- ABL $8.47
- Average True Range (ATR)
- IMTX 0.35
- ABL 0.30
- MACD
- IMTX -0.04
- ABL 0.03
- Stochastic Oscillator
- IMTX 20.41
- ABL 51.55
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
About ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.